fashion -WSS

fashion

author：knowledge 2025-09-28 18:30:36 - browse：14948

George Yancopoulos on the 2024 Breakthrough Summit East stage. — George Yancopoulos on the 2024 Breakthrough Summit East stage STAT

George Yancopoulos is in touch with his teenage self.

After 35 years as head scientist at Regeneron Pharmaceuticals, Yancopoulos has led the development of 12 approved medicines, turning a once-fledgling company into the $100 billion global drugmaker it is today. And you can trace a straight line back to the childhood fascination with science he fostered growing up in Woodside, Queens.

“My high school science project was about regenerating neurons, and ‘Regeneron’ is a contraction of ‘regenerating neurons,’” Yancopoulos said at the STAT Summit East on Thursday. “In some ways I’m still working on my high school science project.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Study finds gene variants tied to breast cancer risk in Black women

focus

WSS

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

HIV drugs protect against transmission, even in unprotected sex

FDA poised to publish guidelines for clinical trial diversity

ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

Making the case for fair compensation in clinical trials

ASCO eve: Let’s set the table for this year's meeting

leisure time

fashion

explore

United colonoscopy coverage change 'may cost lives,' doctors say

BMI, flaws aside, is found to be useful estimate of body fat in youth

Peter Hotez and the public health issue of online harassment

Ionis drug prevents swelling attacks due to hereditary angioedema

How one medical school became remarkably diverse

Addressing health care workers' trauma can help fight burnout

Malaria cases in Florida and Texas: Here’s what you need to know

Citing H5N1 threat, CDC urges peak flu monitoring this summer

Guidelines to prevent youth baseball injuries need more muscle

Innovation in antibiotics is ailing. 'Brain drain' may kill it

knowledge

NIH documents show early flaws of $1.6 billion long Covid program

With trial win, GSK could get blood cancer drug back on market

Shifting the focus from loneliness to social health

For longer

Letters to First Opinion on caregivers, digital health, and more

Kaiser's Risant Health gobbled up Geisinger. Who is next?

focus

knowledge

hotspot

Wikipedia